{
    "clinical_study": {
        "@rank": "98954", 
        "arm_group": {
            "arm_group_label": "Cohort"
        }, 
        "brief_summary": {
            "textblock": "This observational study will evaluate the presence and evolution of fatigue on treatment\n      with RoActemra/Actemra (tocilizumab) in patients with moderate to severe rheumatoid\n      arthritis who have an inadequate response to at least two DMARDs (one of them methotrexate)\n      or to anti-TNF treatment. Patients initiated on treatment with RoActemra/Actemra (8 mg/kg\n      intravenously every 4 weeks) with or without methotrexate will be followed for 4 months."
        }, 
        "brief_title": "An Observational Study on Fatigue in Patients With Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)", 
        "completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "condition": "Rheumatoid Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult patients, >/= 18 years of age\n\n          -  Moderate to severe active rheumatoid arthritis, defined as DAS28 >/= 3.7\n\n          -  Inadequate clinical response to current treatment with >/= 2 non-biologic DMARDs, 1\n             of them being methotrexate optimally administered for >/= 3 months, or inadequate\n             clinical response to anti-TNF therapy\n\n          -  Eligible for RoActemra/Actemra treatment in daily clinical practice\n\n          -  Absence of evolutive tuberculosis (TB)\n\n        Exclusion Criteria:\n\n          -  Hypersensitivity to tocilizumab or any of the excipients\n\n          -  Active, severe infections\n\n          -  Pregnant or lactating women\n\n          -  Participation in any other interventional study\n\n          -  Patients with major depression"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with moderate to severe rheumatoid arthritis with an inadequate response to at\n        least two DMARDs or an inadequate response to anti-TNF treatment, eligible for treatment\n        with RoActemra/Actemra"
            }
        }, 
        "enrollment": {
            "#text": "59", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 15, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01667458", 
            "org_study_id": "ML25702"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 5, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Aalst", 
                        "country": "Belgium", 
                        "zip": "9300"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Assebroek", 
                        "country": "Belgium", 
                        "zip": "8310"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "ATH", 
                        "country": "Belgium", 
                        "zip": "7800"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bruxelles", 
                        "country": "Belgium", 
                        "zip": "1000"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dinant", 
                        "country": "Belgium", 
                        "zip": "5500"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kortrijk", 
                        "country": "Belgium", 
                        "zip": "8500"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lier", 
                        "country": "Belgium", 
                        "zip": "2500"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mons", 
                        "country": "Belgium", 
                        "zip": "7000"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Montignies S/ Sambre", 
                        "country": "Belgium", 
                        "zip": "6061"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Namur", 
                        "country": "Belgium", 
                        "zip": "5000"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Roeselare", 
                        "country": "Belgium", 
                        "zip": "8800"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seraing", 
                        "country": "Belgium", 
                        "zip": "4100"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sijsele-Damme", 
                        "country": "Belgium", 
                        "zip": "8340"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Turnhout", 
                        "country": "Belgium", 
                        "zip": "2300"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Verviers", 
                        "country": "Belgium", 
                        "zip": "4800"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Waremme", 
                        "country": "Belgium", 
                        "zip": "4300"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Westmalle", 
                        "country": "Belgium", 
                        "zip": "2390"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Luxembourg", 
                        "country": "Luxembourg", 
                        "zip": "2763"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Luxembourg"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "F-ACT Trial: Observational Study on Fatigue and Its Evolution During Treatment With Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis in Daily Clinical Practice", 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Belgium: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Evolution of fatigue: Proportion of patients meeting the Minimally Clinically Important Difference (MCID) for the Visual Analogue Sale VAS Fatigue at Week 16", 
            "safety_issue": "No", 
            "time_frame": "16 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01667458"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Fatigue: VAS Fatigue/FACIT Fatigue/Pass Fatigue", 
                "safety_issue": "No", 
                "time_frame": "16 months"
            }, 
            {
                "measure": "Disease Activity Score DAS28", 
                "safety_issue": "No", 
                "time_frame": "16 months"
            }, 
            {
                "measure": "Pain: Visual Analogue Scale VAS Pain", 
                "safety_issue": "No", 
                "time_frame": "16 months"
            }, 
            {
                "measure": "Functional disability: Health Assessment Questionnaire HAQ", 
                "safety_issue": "No", 
                "time_frame": "16 months"
            }, 
            {
                "measure": "Quality of sleep: VAS", 
                "safety_issue": "No", 
                "time_frame": "16 months"
            }, 
            {
                "measure": "Anemia: Haemoglobin levels", 
                "safety_issue": "No", 
                "time_frame": "16 months"
            }, 
            {
                "measure": "Depression: Beck Depression Inventory (BDI) questionnaire", 
                "safety_issue": "No", 
                "time_frame": "16 months"
            }
        ], 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}